Alternative endpoints for mortality in studies of patients with atrial fibrillation: The AFFIRM study experience
- 1 November 2004
- journal article
- Published by Elsevier in Heart Rhythm
- Vol. 1 (5) , 531-537
- https://doi.org/10.1016/j.hrthm.2004.07.007
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Analysis of Cause-Specific Mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) StudyCirculation, 2004
- A Comparison of Rate Control and Rhythm Control in Patients with Atrial FibrillationNew England Journal of Medicine, 2002
- Baseline characteristics of patients with atrial fibrillation: The AFFIRM StudyAmerican Heart Journal, 2002
- Causes of death in the antiarrhythmics versus implantable defibrillators (AVID) trialJournal of the American College of Cardiology, 1999
- Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutterPublished by American Medical Association (AMA) ,1992
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionNew England Journal of Medicine, 1989
- Surrogate endpoints in clinical trials: Definition and operational criteriaStatistics in Medicine, 1989
- Surrogate endpoints in clinical trials: Cardiovascular diseasesStatistics in Medicine, 1989
- Surrogate endpoints in clinical trials: CancerStatistics in Medicine, 1989
- Surrogate endpoints in clinical trials: Ophthalmologic disordersStatistics in Medicine, 1989